FidoCures | Debbie, Todd | - Spoke with 3 reps, Jerry Post
- Targeted exome
- 63 genes for which they have drugs that target those mutations
- 8-10 drugs if correct
- 1,400 dogs
- Shaying is analyzing data from this project
- Some hotspots show similarities between dogs and humans
- FidoCures excited to submit data
- Currently have a sharing method but willing to put in ICDC
- Histopath, Targeted exome
- Followup data probably not available
- Concerned that competitors have made incorrect statements about FidoCures to gain a competitive advantage
- 1-2 ICDC Steering committee members on the boards of these companies
- Concern that sharing all data will hurt FidoCures
- For profit or non-profit?
- Vidium Animal Health?
- FidoCures isn't standardizing follow-up, may impact the data utility
- Who is doing the sequencing for FidoCures?
- Neither Debbie nor Todd remember what FidoCures said
- Can data in ICDC be limited to research use only?
- Could be messy if allowed for commercial purposes
- Currently no restrictions on how data in ICDC
- Does NCI have language around usage restrictions
- Need a conversation with Jason Cristofaro?
- Include Toby, Todd, Amy, Ralph
- If data are submitted, need DGAB and Exec approval
|